Skip Navigation

Your Environment. Your Health.

Major Changes in Budget Request

Fiscal Year 2016 Budget

Major changes by budget mechanism and/or budget activity detail are briefly described below. Note that these highlights will not sum to the total change for the FY 2016 President’s Budget for NIEHS, which is $14.449 million above the FY 2015 Enacted level, for a total of $681.782 million.

Research Project Grants (RPGs) (+$5.735 million; total $251.883 million):
NIEHS plans to support a total of 660 RPG awards in FY 2016. Noncompeting RPGs will decrease by three awards and $6.605 million from the FY 2015 level. Competing RPGs will increase by 34 awards or $12.003 million. $4.917 million of the increase in competing awards will support the new NIH Precision Medicine Initiative. NIEHS will continue to support new investigators in FY 2016.

Precision Medicine ($7.339 million) NIH proposes to launch a national research cohort of one million or more Americans – to propel our understanding of health and disease and set the foundation for a new way of doing research through engaged participants and open, responsible data sharing. Participants who voluntarily choose to join this effort will be able to share their genomic data, biological specimens, and behavioral data, and, if they choose, link it to their electronic health records (EHRs), taking advantage of the latest in social media and mobile applications, and with appropriate privacy protections in place. Bona fide researchers from across the country will have access to data voluntarily provided, thereby crowdsourcing rich data to the brightest minds in biomedical research. The cohort will be built largely by linking existing cohorts together taking advantage of infrastructure, data security and expertise already in place. NIH will help to connect these existing cohorts, but the current sponsors of the cohorts will maintain their ownership and management. Research on this scale promises to lead to new prevention strategies, novel therapeutics and medical devices, and improvements in how we prescribe drugs – on an individual and personalized basis.